Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T K Howard

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Transplantation Proceedings|February 1, 1997
Polymerase chain reaction-triggered preemptive or deferred therapy to control cytomegalovirus-associated morbidity and costs in renal transplant patientsD C Brennan, K A Garlock, B J Lippmann, et al.
The New England Journal of Medicine|November 5, 1999
The economic implications of HLA matching in cadaveric renal transplantationM A Schnitzler, C S Hollenbeak, D S Cohen, et al.
Journal of the American Society of Nephrology : JASN|January 1, 1997
Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapyD C Brennan, K A Garlock, B A Lippmann, et al.
Transplantation|August 19, 2000
The economic benefit of allocation of kidneys based on cross-reactive group matchingC S Hollenbeak, R S Woodward, D S Cohen, et al.
Transplantation Proceedings|February 1, 1997
Pretransplant dobutamine stress echocardiography is useful and cost-effective in renal transplant candidatesD C Brennan, G Vedala, S B Miller, et al.
Transplantation|April 30, 1999
A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipientsD C Brennan, K Flavin, J A Lowell, et al.
Transplantation|January 9, 1998
Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipientsD C Brennan, K A Garlock, G G Singer, et al.
Transplantation Proceedings|May 20, 1999
Leukocyte response to thymoglobulin or atgam for induction immunosuppression in a randomized, double-blind clinical trial in renal transplant recipientsD C Brennan, K Flavin, J A Lowell, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Transplantation Proceedings|February 1, 1997
Polymerase chain reaction-triggered preemptive or deferred therapy to control cytomegalovirus-associated morbidity and costs in renal transplant patientsD C Brennan, K A Garlock, B J Lippmann, et al.
The New England Journal of Medicine|November 5, 1999
The economic implications of HLA matching in cadaveric renal transplantationM A Schnitzler, C S Hollenbeak, D S Cohen, et al.
Journal of the American Society of Nephrology : JASN|January 1, 1997
Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapyD C Brennan, K A Garlock, B A Lippmann, et al.
Transplantation|August 19, 2000
The economic benefit of allocation of kidneys based on cross-reactive group matchingC S Hollenbeak, R S Woodward, D S Cohen, et al.
Transplantation Proceedings|February 1, 1997
Pretransplant dobutamine stress echocardiography is useful and cost-effective in renal transplant candidatesD C Brennan, G Vedala, S B Miller, et al.
Transplantation|April 30, 1999
A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipientsD C Brennan, K Flavin, J A Lowell, et al.
Transplantation|January 9, 1998
Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipientsD C Brennan, K A Garlock, G G Singer, et al.
Transplantation Proceedings|May 20, 1999
Leukocyte response to thymoglobulin or atgam for induction immunosuppression in a randomized, double-blind clinical trial in renal transplant recipientsD C Brennan, K Flavin, J A Lowell, et al.
Pageof 5